Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1882 1
1974 1
1997 1
1998 2
1999 1
2003 1
2004 1
2014 2
2015 3
2016 3
2017 4
2018 2
2019 3
2020 5
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Results by year
Filters applied: . Clear all
Page 1
CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer.
Erdmann S, Niederstadt L, Koziolek EJ, Gómez JDC, Prasad S, Wagener A, von Hacht JL, Reinicke S, Exner S, Bandholtz S, Beindorff N, Brenner W, Grötzinger C. Erdmann S, et al. Among authors: exner s. Theranostics. 2019 Sep 19;9(22):6719-6733. doi: 10.7150/thno.34857. eCollection 2019. Theranostics. 2019. PMID: 31588246 Free PMC article.
Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? - A preclinical assessment in vitro and in vivo.
Briest F, Koziolek EJ, Albrecht J, Schmidt F, Bernsen MR, Haeck J, Kühl AA, Sedding D, Hartung T, Exner S, Welzel M, Fischer C, Grötzinger C, Brenner W, Baum RP, Grabowski P. Briest F, et al. Among authors: exner s. Neoplasia. 2021 Jan;23(1):80-98. doi: 10.1016/j.neo.2020.11.004. Epub 2020 Nov 25. Neoplasia. 2021. PMID: 33246310 Free PMC article.
Accelerated hyperfractionation plus temozolomide in glioblastoma.
Kaul D, Florange J, Badakhshi H, Grün A, Ghadjar P, Exner S, Budach V. Kaul D, et al. Among authors: exner s. Radiat Oncol. 2016 May 21;11:70. doi: 10.1186/s13014-016-0645-3. Radiat Oncol. 2016. PMID: 27209069 Free PMC article.
32 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page